SpineThera is Drug Discovery in United States that focus on drug product candidate business. Founded in 2011. They cover business area such as developer, sustain-release, injectable drug, new treatment option, back pain, its patent-protect sustained-release drug-delivery technology, epidural administration, patient, physician, new treatment drug, risk, outcome, overall treatment cost.
2011
( 13 years old in 2024 )
Drug Product Candidate
-
15600 Medina Road
Suite 247
Plymouth, MN 55447
United States
Private
developersustain-releaseinjectable drugnew treatment optionback painits patent-protect sustained-release drug-delivery technologyepidural administrationpatientphysiciannew treatment drugriskoutcomeoverall treatment cost
* We use standard office opening hours in near SpineThera's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
SpineThera is Drug Discovery business from United States that founded in 2011 (13 years old in 2024), SpineThera business is focusing on Drug Product Candidate.
SpineThera headquarter office and corporate office address is located in 15600 Medina Road Suite 247 Plymouth, MN 55447 United States.
SpineThera was founded in United States.
In 2024, SpineThera is currently focus on drug product candidate sector.
Above is snippet of Google Trends for "drug product candidate" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with SpineThera, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.